5 Results for "

human OGA

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "human OGA" in MCE Product Catalog:

  • Targets Recommended:
54
54 Cited Publications
Cat. No.: HY-12588
CAS No.: 1009816-48-1
Purity:  99.99%
Target:  

OGA Autophagy

Research Areas:  

Cancer

Thiamet G is a potent and selective inhibitor of O-GlcNAcase (OGA), which acts to remove O-GlcNAc from modified proteins, with Ki of 20 nM for human OGA.
loading...
    loading...
Cat. No.: HY-149552
CAS No.: 67561-97-1
Target:  

OGT

Research Areas:  

Cancer

Ac4-5SGlcNAc is an O-GlcNAc transferase (OGT) inhibitor. Ac4-5SGlcNAc converts intracellularly to UDP-5SGlcNAc, which competes with native UDP-GlcNAc (HY-148596) to block OGT catalytic activity, reduces cellular UDP-GlcNAc pools, and limits global protein O-GlcNAcylation. Ac4-5SGlcNAc reduces OGA levels via feedback, alters lectin signal intensities and glycan-related band masses. Ac4-5SGlcNAc can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-RS09757
Research Areas:  

Others

OGA Human Pre-designed siRNA Set A contains three designed siRNAs for OGA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-E71360
Target:  

Glycosidase

Research Areas:  

Others

O-GlcNAcase, Clostridium perfringens is a glycosidase derived from Clostridium perfringens, which functions in bacterial nutrient metabolism, host interaction and virulence regulation. O-GlcNAcase is a core enzyme in the cellular signal regulatory network and serves as a key target for various major and chronic diseases. O-GlcNAcase, Clostridium perfringens can be used for basic research and drug development of O-GlcNAcase due to its high conservation in catalytic mechanism and structure with human-derived enzymes .
loading...
    loading...
Cat. No.: HY-183557
CAS No.: 2407072-65-3
Target:  

OGA

Research Areas:  

Neurological Disease

O-GlcNAcase-IN-6 is an orally active, blood-brain barrier-permeable O-GlcNAcase (OGA) inhibitor with an IC50 of 5.4 nM. O-GlcNAcase-IN-6 inhibits OGA activity, thereby increasing the level of O-GlcNAc glycosylation in brain tissues. O-GlcNAcase-IN-6 can be used for the research of Alzheimer's disease .
loading...
    loading...